EDF posts 17% drop in first-half profit on low power prices
The state-owned utility said earnings before interest, taxes, depreciation and amortisation (EBITDA) for the six months to end-June came to 15.5 billion euros ($18.24 billion), down from 18.7 billion a year earlier.
Net debt stood at 50 billion euros, down from the 54.3 billion euros recorded at the end of last year.
Low power prices are impacting profitability at Europe's leading nuclear power producer as it prepares to build six new reactors over the next 15 years.
Prices have continued to drop from highs hit in 2022 and 2023, with weak industrial demand and higher renewable energy generation pushing prices below the French energy regulator's estimated cost of operating a nuclear plant.
EDF warned in February that its EBITDA would fall by as much as 9 billion euros this year due to weaker prices.
The company will provide a cost estimate for the new plants by the end of this year, CEO Bernard Fontana told reporters, with a final investment decision to be taken in the second half of 2026.
EDF added in a statement that with new bond issues of around 7.4 billion euros and the decrease in interest rates and short-term debt, financing costs were "under control".
($1 = 0.8498 euros)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
a minute ago
- Reuters
Oppenheimer lifts S&P 500 year-end target to Wall Street-high on trade optimism
July 28 (Reuters) - Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index (.SPX), opens new tab to 7,100, the highest among major Wall Street brokerages, betting on easing trade tensions and strong corporate earnings. Its current target implies an 11.13% upside to the benchmark index's last close of 6,388.64. Oppenheimer previously set a target of 5,950 for the index. "With the announcement of trade deals (Japan, EU) by President Trump... we believe that enough 'tariff hurdles' have been overcome for now," Oppenheimer strategists led by John Stoltzfus said in a note. The U.S. and European Union finalised a trade deal on Sunday, that sets a 15% tariff on most European goods including cars, semiconductors and pharmaceuticals, while the EU pledged to buy $750 billion in U.S. energy and invest $600 billion in the U.S. economy. Last week, U.S. President Donald Trump struck a $550 billion deal with Japan. Earlier this month, Goldman Sachs, Bank of America, and RBC Capital Markets also raised their S&P 500 targets The S&P 500 has rebounded 28.2% since its April 8 low, following Trump's 'Liberation Day' tariffs, broadly driven by cyclical sectors such as technology, industrials and communication services. Oppenheimer brought back its S&P 500 earnings estimate to $275, which it had originally set in December 2024, having trimmed its projection to $265 in April. Stoltzfus continues to favor U.S. equities, particularly cyclical stocks, and sees further upside as inflation moderates and expects the Federal Reserve to hold interest rates steady in this week's policy meeting.
Reuters
a minute ago
- Reuters
What's in Trump's trade deal with Europe?
BRUSSELS, July 28 (Reuters) - The United States and the European Union agreed on a framework trade deal, which leaders on both sides of the Atlantic said would end months of uncertainty for industries and consumers. Here are the main elements of the deal that will enter into force on August 1 through an executive order by President Donald Trump, according to EU officials: * BASELINE TARIFF RATE: Almost all EU goods entering the U.S. will be subject to a 15% baseline tariff. The 15% tariff is not added to any existing rates. * CARS: Cars and car parts will be subject to the 15% tariff, compared to the 27.5% they face now. * PHARMACEUTICALS AND SEMICONDUCTORS: Pharmaceuticals and microchips will face a 0% tariff until the U.S. concludes Section 232 trade investigations in a few weeks and imposes new global tariff rates on the two industries. The levy on pharmaceuticals and microchips imported from Europe will not exceed 15%, irrespective of the tariffs applied more widely. * TIMBER AND COPPER: Tariffs will be applied after the conclusion of 232 investigations into those sectors. The duties on European lumber and copper will not exceed 15%. * STEEL AND ALUMINIUM: Tariffs on European steel and aluminium will stay at 50%, for now, but the EU and the U.S. agreed that they will be replaced by a quota system that will be negotiated later. European steel exports within the agreed quota would face the most-favoured nation tariff rate agreed under WTO rules, which are low and in some cases zero depending on the steel grade. Steel exports outside of the quota would be at 50%. * ZERO-FOR-ZERO tariffs: The U.S. and EU will have zero-for-zero tariffs on: - all aircraft and their components, - certain chemicals, - certain generic drugs, - semiconductor-making equipment, - some agricultural products but with the exclusion of all sensitive products like beef, rice, ethanol, sugar or poultry. - Natural resources and critical raw materials. More products are to be added. * WINE AND SPIRITS: A tariff rate for wine and spirits - a point of friction on both sides of the Atlantic - is still to be established. * STRATEGIC PURCHASES: The EU pledged to make $750 billion in strategic purchases, covering oil, liquefied natural gas (LNG) and nuclear technology during U.S. President Donald Trump's term in office. This will come as a mix of spot purchases for oil, long-term contracts for LNG and government procurement for nuclear technology. The amount has been estimated on the basis of Europe's planned phase out of energy purchases from Russia. EU purchases of U.S. microchips would be on top of the $750 billion. The U.S. will be the preferred vendor. * European companies are to invest $600 billion in the U.S. over the course of Trump's second term. Japan's package will consist of equity, loans and guarantees from state-run agencies of up to $550 billion to be invested at Trump's discretion, Tokyo says. EU officials, in contrast, said Europe's $600 billion investment pledge is based on the combined investment intentions expressed by European companies. * DEFENCE PROCUREMENT: EU member states will purchase U.S. military equipment. The deal does not specify an amount.
Reuters
a minute ago
- Reuters
Is U.S. stock rally near 'Mag 7' turning point?
ORLANDO, Florida, July 28 (Reuters) - As investors brace for the busiest week of the U.S. earnings season, with four of the 'Magnificent Seven' tech giants reporting, debate is picking up again about these megacap firms' influence over U.S. equity indexes and whether we could be seeing the beginnings of true market broadening. By some measures, this small clutch of tech titans' profits, market cap, and valuations as a share of the wider market has never been bigger. Broader indices are at record highs, but strip out these firms and the picture is much less rosy. Indeed, since the beginning of 2023, the S&P 500 composite - the benchmark 'market cap' index increasingly dominated by the 'Mag 7' - has gained 67%, more than double the 'equal-weight' index's 32%. Only two years ago, the S&P 500 composite/equal-weight ratio was 0.66, meaning the composite index was worth around two-thirds of the equal weight index. That ratio is now 0.84, the highest since 2003. There's good reason for that. According to Larry Adam, chief investment officer at Raymond James, 12-month forward earnings estimates for the S&P 500 have outpaced estimates for the equal-weight index by 14%. And Tajinder Dhillon, senior research analyst at LSEG, notes that the 'Mag 7' last year accounted for 52% of overall earnings growth. Many investors and analysts consider it unhealthy to have the fate of the entire market dependent on so few companies. It may be fine when they're flying high, but not so much if one or two of them take a dive. Plus, it makes stock picking more difficult. If the market basically goes where the 'Mag 7' or Nvidia go, why should an investor bother buying anything else? That's a recipe for market inefficiencies. There have recently been nascent signs that the market may be broadening out beyond tech and AI-related names, largely thanks to positive news on the trade front. Last week, the equal-weight index eclipsed November's high to set a fresh record. Raymond James's CIO Adam notes that the equal-weight index outperformed the S&P 500 last week for the fourth week in the last 13. More of the same this week would mark its first monthly outperformance since March. Can it hit this mark? Around 160 of the S&P 500-listed firms report this week, including Meta and Microsoft on Wednesday and Amazon and Apple on Wednesday. It's not a stretch to say these four reports will move the market more than the rest combined. LSEG's Dhillon says the Mag 7's share of total earnings growth is expected to fall to 37% this year and 27% next year. The expected earnings growth spread between Mag 7 and the wider index in the second quarter - 16.4% vs. 7.7% - is the smallest since 2023, and will shrink more in Q3, he adds. [Why does he believe this will be the case?] Larry Adam at Raymond James, however, thinks the recent market broadening is a "short-term normalization" rather than a "material shift". He thinks the earnings strength of the tech-related sectors justifies the valuation premium on these stocks. Regardless, what we know for sure is that fears about the market's concentration and narrowness have been swirling for years and there has yet to be a reckoning. The equal-weight index's rise to new highs last week suggests the rising tide is lifting all boats, not just the billionaire's yachts. Essentially, the Mag 7 and large caps are outperforming, but if you peel back the onion, other sectors like financials and industrials are also doing well. And look around the world. Many indices outside the U.S. that aren't tech-heavy are approaching or printing new highs also, like Britain's FTSE 100 and Germany's DAX. "To see the largest names leading isn't a worrisome sign, especially as they are backing it up with very strong earnings," says Ryan Detrick, chief market strategist at Carson Group. "This isn't a weak breadth market, it is broad based and a very healthy rally." This week's earnings might go some way to determining whether this continues for a while yet. (The opinions expressed here are those of the author, a columnist for Reuters)
